EconPapers    
Economics at your fingertips  
 

GlaxoSmithKline and its Corporate Citizenship Programme

Ian W. Jones, Michael Pollitt and David Bek
Additional contact information
Ian W. Jones: University of Oxford
David Bek: University of Cambridge

Chapter 9 in Multinationals in their Communities, 2007, pp 260-281 from Palgrave Macmillan

Abstract: Abstract GSK’s history is based around a series of mergers and acquisitions, dating back to the opening of John K. Smith’s drug store in Philadelphia in 1830. Key dates in the firm’s history include: the building of the world’s first medicine factory by Thomas Beecham in 1859, the opening of the Wellcome Tropical Research Laboratories in 1902 and the registration of Glaxo as a trademark for dried baby milk in 1906 (GSK, 2005i). In 2000 Smithkline Beecham (which had formed in 1989) and Glaxo Wellcome (who had merged in 1995) joined forces to create GSK — one of the world’s leading research-based pharmaceutical companies (GSK, 2005k). The firm is headquartered in the UK with operational headquarters based in the US and operations in 118 countries. The firm has two main divisions — pharmaceutical and consumer healthcare. The pharmaceutical division (which generates about 85% of GSK’s sales) deals predominantly with vaccines and prescriptions drugs, whilst the consumer healthcare side produces over-the-counter medicines, healthcare products and nutritional drinks. Well-known products include, Zantac and Paxil/Seroxat (pharmaceuticals) and Macleans toothpaste and Lucozade (consumer healthcare).

Keywords: Social Capital; Corporate Responsibility; Lymphatic Filariasis; Corporate Philanthropy; Global Alliance (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-21105-6_9

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230211056

DOI: 10.1057/9780230211056_9

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-04-01
Handle: RePEc:pal:palchp:978-0-230-21105-6_9